{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T06:54:14Z","timestamp":1791356054443,"version":"4.3.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2006,12,1]],"date-time":"2006-12-01T00:00:00Z","timestamp":1164931200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Pharmaceutics"],"published-print":{"date-parts":[[2006,12]]},"DOI":"10.1016\/j.ijpharm.2006.07.022","type":"journal-article","created":{"date-parts":[[2006,7,19]],"date-time":"2006-07-19T14:30:22Z","timestamp":1153319422000},"page":"32-38","source":"Crossref","is-referenced-by-count":45,"title":["Investigation into the potential of low-frequency ultrasound facilitated topical delivery of Cyclosporin A"],"prefix":"10.1016","volume":"326","author":[{"given":"Hongzhuo","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanming","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weisan","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongjun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huimin","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpharm.2006.07.022_bib1","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0378-5173(88)90101-9","article-title":"Phonophoresis of lingocaine and prilocaine from EMLA cream","volume":"44","author":"Benson","year":"1988","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2006.07.022_bib2","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ijpharm.2004.01.016","article-title":"Iontophoresis of lecithin vesicles of Cyclosporin A","volume":"274","author":"Boinpally","year":"2004","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2006.07.022_bib3","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0378-5173(01)00820-1","article-title":"In vitro study of low-frequency ultrasound-enhanced transdermal transport of fentanyl and caffeine across human and hairless rat skin","volume":"228","author":"Boucaud","year":"2001","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2006.07.022_bib4","first-page":"113","article-title":"Effect of sonication parameters on transdermal delivery of insulin to hairless rats","volume":"91","author":"Boucaud","year":"2002","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2006.07.022_bib5","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/jps.2600840512","article-title":"Percutaneous absorption and dermal delivery of Cyclosporin A","volume":"84","author":"Choi","year":"1995","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2006.07.022_bib6","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/0005-2736(90)90289-Z","article-title":"Membrane electroporation-fast molecular exchange by electroosmosis","volume":"1022","author":"Dimitrov","year":"1990","journal-title":"Biochim. Biophys. Acta."},{"key":"10.1016\/j.ijpharm.2006.07.022_bib7","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/j.1365-2133.1990.tb01480.x","article-title":"Enhanced percutaneous absorption of a novel topical Cyclosporin A formulation and assessment of its immunosuppressive activity","volume":"123","author":"Duncan","year":"1990","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.ijpharm.2006.07.022_bib8","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0168-3659(94)00132-E","article-title":"Analysis of enhanced transdermal transport by skin electroporation","volume":"34","author":"Edwards","year":"1995","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2006.07.022_bib9","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0733-8635(05)70415-0","article-title":"Recent advances in the treatment of psoriasis","volume":"15","author":"Guzzo","year":"1997","journal-title":"Dermatol. Clin."},{"key":"10.1016\/j.ijpharm.2006.07.022_bib10","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1159\/000086739","article-title":"Immunomodulation and safety of topical calcineurin inhibitors for the treatment of atopic dermatitis","volume":"211","author":"Hultsch","year":"2005","journal-title":"Dermatology"},{"key":"10.1016\/j.ijpharm.2006.07.022_bib11","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/S1359-6446(04)03170-8","article-title":"Ultrasound and transdermal drug delivery","volume":"9","author":"IIana","year":"2004","journal-title":"Drug. Deliv. Today"},{"key":"10.1016\/j.ijpharm.2006.07.022_bib12","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1021\/js960079z","article-title":"Synergistic effect of ultrasound and chemical enhancers on transdermal drug delivery","volume":"85","author":"Johnson","year":"1996","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2006.07.022_bib13","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/S0006-3495(91)82115-4","article-title":"Electrically induced DNA uptake by cells is a fast process involving DNA electrophoresis","volume":"60","author":"Klenchin","year":"1991","journal-title":"Biophys. J."},{"key":"10.1016\/j.ijpharm.2006.07.022_bib14","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1023\/A:1016070710397","article-title":"Enhanced transdermal delivery: synergistic effect of ultrasound and electroporation","volume":"13","author":"Kost","year":"1996","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2006.07.022_bib15","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0939-6411(03)00138-3","article-title":"Cyclosporin A delivery to the eye: a pharmaceutical challenge","volume":"56","author":"Lallemand","year":"2003","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpharm.2006.07.022_bib16","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.jconrel.2005.06.011","article-title":"The nature of ultrasound-SLS synergism during enhanced transdermal transport","volume":"107","author":"Lavon","year":"2005","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2006.07.022_bib17","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1080\/03639040500529168","article-title":"Bicontinuous water-AOT\/Tween85-isopropylmytistate microemulsion: a new vehicle for transdermal delivery of Cyclosporin A","volume":"32","author":"Liu","year":"2006","journal-title":"Drug. Dev. Ind. Pharm."},{"key":"10.1016\/j.ijpharm.2006.07.022_bib18","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.ijpharm.2005.12.029","article-title":"Effect of vehicles and enhancers on the topical delivery of cyclosporin A","volume":"311","author":"Liu","year":"2006","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2006.07.022_bib19","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ejpb.2004.12.003","article-title":"Topical delivery of Cyclosporin A: an in vitro study using monoolein as a penetration enhancer","volume":"60","author":"Lopes","year":"2005","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpharm.2006.07.022_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0378-5173(02)00299-5","article-title":"Phonophoresis: efficiency, mechanisms and skin tolerance","volume":"243","author":"Machet","year":"2002","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2006.07.022_bib21","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1023\/A:1007522114438","article-title":"Synergistic effect of enhancers for transdermal drug delivery","volume":"17","author":"Mitragotri","year":"2000","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2006.07.022_bib22","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1126\/science.7638603","article-title":"Ultrasound-mediated transdermal protein delivery","volume":"269","author":"Mitragotri","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.ijpharm.2006.07.022_bib23","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1023\/A:1016096626810","article-title":"Transdermal drug delivery using low-frequency sonophoresis","volume":"13","author":"Mitragotri","year":"1996","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2006.07.022_bib24","first-page":"176","article-title":"Enhancement of transdermal transport using ultrasound and surfactants","volume":"26","author":"Mitragotri","year":"1999","journal-title":"Proc. Ind. Symp. Control. Release Bioact. Mater."},{"key":"10.1016\/j.ijpharm.2006.07.022_bib25","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0168-3659(99)00178-9","article-title":"Determination of threshold energy dose for ultrasound induced transdermal drug transport","volume":"63","author":"Mitragotri","year":"2000","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2006.07.022_bib26","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1002\/1520-6017(200007)89:7<892::AID-JPS6>3.0.CO;2-V","article-title":"Synergistic effect of ultrasound and sodium lauryl sulphate on transdermal drug delivery","volume":"89","author":"Mitragotri","year":"2000","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2006.07.022_bib27","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1023\/A:1010979010907","article-title":"Transdermal delivery of heparin and low-molecular weight heparin using low frequency ultrasound","volume":"18","author":"Mitragotri","year":"2001","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2006.07.022_bib28","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.addr.2003.10.024","article-title":"Low-frequency sonophoresis","volume":"56","author":"Mitragotri","year":"2004","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijpharm.2006.07.022_bib29","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1016\/S0006-3495(95)80363-2","article-title":"Millisecond measurement of transport during and after an electroporation pulse","volume":"68","author":"Prausnitz","year":"1995","journal-title":"Biophys. J."},{"key":"10.1016\/j.ijpharm.2006.07.022_bib30","doi-asserted-by":"crossref","first-page":"24","DOI":"10.5070\/D34PC7M5D9","article-title":"Intradermal drug delivery by low-frequency sonophoresis (25kHz)","volume":"10","author":"Santoianni","year":"2004","journal-title":"Dermatol. Online J."},{"key":"10.1016\/j.ijpharm.2006.07.022_bib31","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1023\/A:1019898109793","article-title":"An investigation of the role of cavitation in low-frequency ultrasound mediated transdermal drug transport","volume":"19","author":"Tang","year":"2002","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2006.07.022_bib32","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1023\/A:1015869420159","article-title":"Transdermal delivery of insulin to alloxan-diabetic rabbits by ultrasound exposure","volume":"9","author":"Tachibana","year":"1992","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2006.07.022_bib33","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0378-5173(01)00981-4","article-title":"Dependence of low-frequency sonophoresis on ultrasound parameters: distance of the horn and intensity","volume":"235","author":"Terahara","year":"2002","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2006.07.022_bib34","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1023\/A:1013366328457","article-title":"Frequency dependence of sonophoresis","volume":"18","author":"Tezel","year":"2001","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2006.07.022_bib35","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1006\/jsre.1999.5582","article-title":"Site-specific immunosuppression using a new formulation of topical cyclosporine A with polyethylene glycol-8 glyceryl caprylate\/caprate","volume":"83","author":"Tran","year":"1999","journal-title":"J. Surg. Res."},{"key":"10.1016\/j.ijpharm.2006.07.022_bib36","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1046\/j.1468-3083.2000.00097-14.x","article-title":"Treatment of alopecia areata in the DEBR model using Cyclosporin A lipid vesicles","volume":"14","author":"Verma","year":"2004","journal-title":"Eur. J. Dermatol."},{"key":"10.1016\/j.ijpharm.2006.07.022_bib37","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jconrel.2004.02.028","article-title":"Synergistic penetration enhancement effect of ethanol and phosphoilipids on the topical delivery of Cyclosporin A","volume":"97","author":"Verma","year":"2004","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2006.07.022_bib38","first-page":"671","article-title":"The use of cyclosporin in psoriasis: a clinical review","volume":"150","author":"Vc","year":"2004","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.ijpharm.2006.07.022_bib39","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0168-3659(97)00117-X","article-title":"Transdermal delivery of Cyclosporin A using electroporation","volume":"50","author":"Wang","year":"1998","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2006.07.022_bib40","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/j.1365-2133.1997.tb02136.x","article-title":"Renal biopsy findings in long-term cyclosporin treatment of psoriasis","volume":"136","author":"Zachariae","year":"1997","journal-title":"Br. J. Dermatol."}],"container-title":["International Journal of Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517306005564?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517306005564?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,7,29]],"date-time":"2021-07-29T23:02:05Z","timestamp":1627599725000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378517306005564"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,12]]},"references-count":40,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2006,12]]}},"alternative-id":["S0378517306005564"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpharm.2006.07.022","relation":{},"ISSN":["0378-5173"],"issn-type":[{"value":"0378-5173","type":"print"}],"subject":[],"published":{"date-parts":[[2006,12]]}}}